Innerer Wert von S&P & Nasdaq Kontaktieren

Koninklijke DSM N.V. RDSMY OTC

Other OTC • Basic Materials • Chemicals - Specialty • NL • USD

SharesGrow Score
68/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Koninklijke DSM N.V. (RDSMY) ist ein börsennotiertes Unternehmen im Grundstoffe Sektor, tätig in der Chemicals - Specialty Branche. Der Hauptsitz des Unternehmens ist in Heerlen, Netherlands. Der aktuelle CEO ist Dimitri de Vreeze.

RDSMY hat IPO-Datum 2001-07-16, 21,760 Vollzeitbeschäftigte, gelistet an der Other OTC.

Über Koninklijke DSM N.V.

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.

📍 Het Overloon 1, Heerlen 6411 TE 📞 31 45 578 8111
Unternehmensdetails
SektorGrundstoffe
BrancheChemicals - Specialty
LandNetherlands
BörseOther OTC
WährungUSD
IPO-Datum2001-07-16
CEODimitri de Vreeze
Mitarbeiter21,760
Handelsinformationen
Aktueller Kurs$33.85
52-Wochen-Spanne26.59-56.92
Beta0.79
ETFNein
ADRNein
CUSIP23332H202
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden